2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effect of Chlorhexidine Bathing Every Other Day on Prevention of Hospital-Acquired Infections in the Surgical ICU: A Single-Center, Randomized Controlled Trial.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To test the hypothesis that compared with daily soap and water bathing, 2% chlorhexidine gluconate bathing every other day for up to 28 days decreases the risk of hospital-acquired catheter-associated urinary tract infection, ventilator-associated pneumonia, incisional surgical site infection, and primary bloodstream infection in surgical ICU patients.

          Related collections

          Author and article information

          Journal
          Crit. Care Med.
          Critical care medicine
          Ovid Technologies (Wolters Kluwer Health)
          1530-0293
          0090-3493
          Oct 2016
          : 44
          : 10
          Affiliations
          [1 ] 1Department of Pharmacy Practice and Clinical Health Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX.2Allied Health Sciences, Institute for Academic Medicine, Houston Methodist Research Institute, Houston, TX.3Department of Pharmacy, Houston Methodist Hospital, Houston, TX.4Center for Outcomes Research, Department of Surgery, Houston Methodist Research Institute, Houston, TX.5Department of Surgery, Houston Methodist Hospital, Houston, TX.6Department of Surgery, Weill Cornell Medical College, New York, NY.7Department of Pharmacy, Memorial Hermann Greater Heights Hospital, Houston, TX.8Surgical Intensive Care Unit, Houston Methodist Hospital, Houston, TX.9Ambulatory Treatment Center, MD Anderson Cancer Center, Houston, TX.10Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX.11Rapides Regional Physician Group, Rapides Regional Medical Center, Alexandria, LA.12Novartis Pharmaceuticals Corporation, East Hanover, NJ.13Division of Acute Care Surgery and Surgical Critical Care, Department of Surgery, Houston Methodist Hospital, Houston, TX.14Infection Prevention and Control, Houston Methodist Hospital, Houston, TX.15Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX.
          Article
          10.1097/CCM.0000000000001820
          27428384
          e52d1c7d-1536-4b4c-ba0f-0557e39c0b0f
          History

          Comments

          Comment on this article